BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21602736)

  • 1. Evidence of an intracellular angiotensin-generating system and non-AT1, non-AT2 binding site in a human pancreatic cell line.
    Pérez-Díaz I; Guzmán C; Olivares-Reyes JA; Ramírez T; Gutierréz-Reyes G; Hiriart M; Robles-Díaz G
    Pancreas; 2011 Jul; 40(5):701-7. PubMed ID: 21602736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
    Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL
    Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells.
    Gong Q; Davis M; Chipitsyna G; Yeo CJ; Arafat HA
    Pancreas; 2010 Jul; 39(5):581-94. PubMed ID: 20118823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptors in hormone-independent prostate cancer cell line DU145: presence of two variants of angiotensin type 1 receptor.
    Sidorkiewicz M; Rebas E; Szymajda M; Ławnicka H; Pawlikowski M; Lachowicz A
    Med Sci Monit; 2009 Apr; 15(4):BR106-10. PubMed ID: 19333191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
    J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of angiotensin II type 1 (AT1) and angiotensin II type 2 (AT2) receptors in human granulosa-lutein (GL) cells: correlation with infertility diagnoses.
    Peña O; Palumbo A; González-Fernández R; Hernández J; Naftolin F; Avila J
    Fertil Steril; 2010 Mar; 93(5):1601-8. PubMed ID: 19524223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
    Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
    Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis.
    Tsang SW; Cheng CH; Leung PS
    Regul Pept; 2004 Jul; 119(3):213-9. PubMed ID: 15120483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
    Zhao Y; Peng J; Zheng L; Yu W; Jin J
    Prostate; 2010 Jun; 70(8):899-905. PubMed ID: 20135646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor.
    Redondo-Müller MA; Stevanovic-Walker M; Barker S; Puddefoot JR; Vinson GP
    Endocr Relat Cancer; 2008 Mar; 15(1):277-88. PubMed ID: 18310294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain.
    Karamyan VT; Speth RC
    Brain Res; 2007 Apr; 1143():83-91. PubMed ID: 17306233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
    Anandanadesan R; Gong Q; Chipitsyna G; Witkiewicz A; Yeo CJ; Arafat HA
    J Gastrointest Surg; 2008 Jan; 12(1):57-66. PubMed ID: 18026817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
    Weiland F; Verspohl EJ
    Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of angiotensin II receptors in proliferation of fibroblast derived from human hypertrophic scars].
    Liu HW; Cheng B; Yu WL; Sun RX; Tang JB; Fu XB
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Jan; 23(1):36-9. PubMed ID: 17393691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects.
    Unger T; Sandmann S
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S6-9. PubMed ID: 17199211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
    Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
    Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cells.
    Andresen BT; Romero GG; Jackson EK
    J Pharmacol Exp Ther; 2004 Apr; 309(1):425-31. PubMed ID: 14722318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.